161 related articles for article (PubMed ID: 35331302)
21. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD
PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187
[TBL] [Abstract][Full Text] [Related]
22. Pioneer transcription factors are associated with the modulation of DNA methylation patterns across cancers.
Lemma RB; Fleischer T; Martinsen E; Ledsaak M; Kristensen V; Eskeland R; Gabrielsen OS; Mathelier A
Epigenetics Chromatin; 2022 Apr; 15(1):13. PubMed ID: 35440061
[TBL] [Abstract][Full Text] [Related]
23. Mapping the regulatory sequences controlling 93 breast cancer-associated miRNA genes leads to the identification of two functional promoters of the Hsa-mir-200b cluster, methylation of which is associated with metastasis or hormone receptor status in advanced breast cancer.
Wee EJ; Peters K; Nair SS; Hulf T; Stein S; Wagner S; Bailey P; Lee SY; Qu WJ; Brewster B; French JD; Dobrovic A; Francis GD; Clark SJ; Brown MA
Oncogene; 2012 Sep; 31(38):4182-95. PubMed ID: 22231446
[TBL] [Abstract][Full Text] [Related]
24. Exploring DNA methylation changes in promoter, intragenic, and intergenic regions as early and late events in breast cancer formation.
Rauscher GH; Kresovich JK; Poulin M; Yan L; Macias V; Mahmoud AM; Al-Alem U; Kajdacsy-Balla A; Wiley EL; Tonetti D; Ehrlich M
BMC Cancer; 2015 Oct; 15():816. PubMed ID: 26510686
[TBL] [Abstract][Full Text] [Related]
25. Bioinformatics analysis of abnormal DNA methylation in muscle samples from monozygotic twins discordant for type 2 diabetes.
Liu F; Sun Q; Wang L; Nie S; Li J
Mol Med Rep; 2015 Jul; 12(1):351-6. PubMed ID: 25760736
[TBL] [Abstract][Full Text] [Related]
26. Molecular mechanisms for aberrant expression of the human breast cancer specific gene 1 in breast cancer cells: control of transcription by DNA methylation and intronic sequences.
Lu A; Gupta A; Li C; Ahlborn TE; Ma Y; Shi EY; Liu J
Oncogene; 2001 Aug; 20(37):5173-85. PubMed ID: 11526506
[TBL] [Abstract][Full Text] [Related]
27. Effects of methylation on expression of TMS1/ASC in human breast cancer cells.
Levine JJ; Stimson-Crider KM; Vertino PM
Oncogene; 2003 May; 22(22):3475-88. PubMed ID: 12776200
[TBL] [Abstract][Full Text] [Related]
28. DNA methylation at enhancers identifies distinct breast cancer lineages.
Fleischer T; Tekpli X; Mathelier A; Wang S; Nebdal D; Dhakal HP; Sahlberg KK; Schlichting E; ; Børresen-Dale AL; Borgen E; Naume B; Eskeland R; Frigessi A; Tost J; Hurtado A; Kristensen VN
Nat Commun; 2017 Nov; 8(1):1379. PubMed ID: 29123100
[TBL] [Abstract][Full Text] [Related]
29. Prediction of epigenetically regulated genes in breast cancer cell lines.
Loss LA; Sadanandam A; Durinck S; Nautiyal S; Flaucher D; Carlton VE; Moorhead M; Lu Y; Gray JW; Faham M; Spellman P; Parvin B
BMC Bioinformatics; 2010 Jun; 11():305. PubMed ID: 20525369
[TBL] [Abstract][Full Text] [Related]
30. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive analysis reveals common DNA methylation patterns of tobacco-associated cancers: A pan-cancer analysis.
Liu X; Chen J; Li J; Zeng Z; Jiang X; Gao Y; Huang Z; Wu Q; Gong Y; Xie C
Gene; 2021 Dec; 804():145900. PubMed ID: 34400279
[TBL] [Abstract][Full Text] [Related]
32. Integrated analysis of genome-wide DNA methylation and gene expression profiles in molecular subtypes of breast cancer.
Rhee JK; Kim K; Chae H; Evans J; Yan P; Zhang BT; Gray J; Spellman P; Huang TH; Nephew KP; Kim S
Nucleic Acids Res; 2013 Oct; 41(18):8464-74. PubMed ID: 23887935
[TBL] [Abstract][Full Text] [Related]
33. Comparative pan-cancer DNA methylation analysis reveals cancer common and specific patterns.
Yang X; Gao L; Zhang S
Brief Bioinform; 2017 Sep; 18(5):761-773. PubMed ID: 27436122
[TBL] [Abstract][Full Text] [Related]
34. Hypomethylation coordinates antagonistically with hypermethylation in cancer development: a case study of leukemia.
Kushwaha G; Dozmorov M; Wren JD; Qiu J; Shi H; Xu D
Hum Genomics; 2016 Jul; 10 Suppl 2(Suppl 2):18. PubMed ID: 27461342
[TBL] [Abstract][Full Text] [Related]
35. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
[TBL] [Abstract][Full Text] [Related]
36. Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer.
Muggerud AA; Rønneberg JA; Wärnberg F; Botling J; Busato F; Jovanovic J; Solvang H; Bukholm I; Børresen-Dale AL; Kristensen VN; Sørlie T; Tost J
Breast Cancer Res; 2010; 12(1):R3. PubMed ID: 20056007
[TBL] [Abstract][Full Text] [Related]
37. Cooperativity of co-factor NR2F2 with Pioneer Factors GATA3, FOXA1 in promoting ERα function.
Jiang G; Wang X; Sheng D; Zhou L; Liu Y; Xu C; Liu S; Zhang J
Theranostics; 2019; 9(22):6501-6516. PubMed ID: 31588232
[TBL] [Abstract][Full Text] [Related]
38. Identification of aberrantly methylated differentially expressed genes in breast cancer by integrated bioinformatics analysis.
Yi L; Luo P; Zhang J
J Cell Biochem; 2019 Sep; 120(9):16229-16243. PubMed ID: 31081184
[TBL] [Abstract][Full Text] [Related]
39. Genome-wide DNA methylation analysis identifies candidate epigenetic markers and drivers of hepatocellular carcinoma.
Zheng Y; Huang Q; Ding Z; Liu T; Xue C; Sang X; Gu J
Brief Bioinform; 2018 Jan; 19(1):101-108. PubMed ID: 27760737
[TBL] [Abstract][Full Text] [Related]
40. Identification of 20 genes aberrantly methylated in human breast cancers.
Miyamoto K; Fukutomi T; Akashi-Tanaka S; Hasegawa T; Asahara T; Sugimura T; Ushijima T
Int J Cancer; 2005 Sep; 116(3):407-14. PubMed ID: 15818620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
